Abstract
Background
18-Fluorine sodium fluoride is a well-known radiotracer used for bone metastasis diagnosis. Its uptake correlation with cardiovascular (CV) risk was primarily suggested in oncological patients. Moreover, as a specific marker of microcalcification, it seems to correlate with CV disease progression and plaque instability.
Methods and Results
Our purpose was to systematically review clinical studies that characterized the use of this marker in CV conditions. In atherosclerosis, most studies report a positive correlation with the burden of CV risk factors and vascular calcification. A higher uptake was found in culprit plaques/rupture sites in coronary and carotid arteries and it was also linked to high-risk features in histology and intravascular imaging analysis of the plaques. In aortic stenosis, this tracer displayed an increasing uptake with disease severity.
Conclusions
Sodium fluoride positron emission tomography is a promising non-invasive technique to identify high-risk plaques, which sets ground to a potential use of this tracer in evaluating atherosclerotic disease progression and degenerative changes in aortic valve stenosis. Nevertheless, there is a need for further prospective evidence that demonstrates this technique’s value in predicting clinical events, adjusting treatment strategies, and improving patient outcomes.
Similar content being viewed by others
Abbreviations
- 18F-NaF:
-
Fluorine-18 sodium fluoride
- AAA:
-
Abdominal aortic aneurysm
- AVS:
-
Aortic valve stenosis
- CT:
-
Computed tomography
- CV:
-
Cardiovascular
- CVD:
-
Cardiovascular disease
- MI:
-
Myocardial infarction
- PET:
-
Positron emission tomography
References
Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1995;92:1355-74.
Pawade TA, Newby DE, Dweck MR. Calcification in aortic stenosis: The skeleton key. J Am Coll Cardiol 2015;66:561-77.
Irkle A, Vesey AT, Lewis DY, et al. Identifying active vascular microcalcification by (18)F-sodium fluoride positron emission tomography. Nat Commun 2015;6:7495.
Hawkins RA, Choi Y, Huang SC, et al. Evaluation of the skeletal kinetics of fluorine-18-fluoride ion with PET. J Nucl Med 1992;33:633-42.
Blake GM, Park-Holohan SJ, Cook GJ, Fogelman I. Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate. Semin Nucl Med 2001;31:28-49.
Vesey AT, Jenkins WS, Irkle A, et al. (18)F-fluoride and (18)F-fluorodeoxyglucose positron emission tomography after transient ischemic attack or minor ischemic stroke: Case–control study. Circ Cardiovasc Imaging 2017. https://doi.org/10.1161/CIRCIMAGING.116.004976.
Joshi NV, Vesey AT, Williams MC, et al. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: A prospective clinical trial. Lancet 2014;383:705-13.
Derlin T, Richter U, Bannas P, et al. Feasibility of 18F-sodium fluoride PET/CT for imaging of atherosclerotic plaque. J Nucl Med 2010;51:862-5.
Derlin T, Toth Z, Papp L, et al. Correlation of inflammation assessed by 18F-FDG PET, active mineral deposition assessed by 18F-fluoride PET, and vascular calcification in atherosclerotic plaque: A dual-tracer PET/CT study. J Nucl Med 2011;52:1020-7.
Derlin T, Wisotzki C, Richter U, et al. In vivo imaging of mineral deposition in carotid plaque using 18F-sodium fluoride PET/CT: Correlation with atherogenic risk factors. J Nucl Med 2011;52:362-8.
Li Y, Berenji GR, Shaba WF, Tafti B, Yevdayev E, Dadparvar S. Association of vascular fluoride uptake with vascular calcification and coronary artery disease. Nucl Med Commun 2012;33:14-20.
Janssen T, Bannas P, Herrmann J, et al. Association of linear (1)(8)F-sodium fluoride accumulation in femoral arteries as a measure of diffuse calcification with cardiovascular risk factors: A PET/CT study. J Nucl Cardiol 2013;20:569-77.
Kurata S, Tateishi U, Shizukuishi K, et al. Assessment of atherosclerosis in oncologic patients using 18F-fluoride PET/CT. Ann Nucl Med 2013;27:481-6.
Ishiwata Y, Kaneta T, Nawata S, Hino-Shishikura A, Yoshida K, Inoue T. Quantification of temporal changes in calcium score in active atherosclerotic plaque in major vessels by (18)F-sodium fluoride PET/CT. Eur J Nucl Med Mol Imaging 2017;44:1529-37.
Ferreira MJV, Oliveira-Santos M, Silva R, et al. Assessment of atherosclerotic plaque calcification using 18F-NaF PET–CT. J Nucl Cardiol 2018;25:1733-41.
Oliveira-Santos M, Castelo-Branco M, Silva R, et al. Atherosclerotic plaque metabolism in high cardiovascular risk subjects—A subclinical atherosclerosis imaging study with (18)F-NaF PET–CT. Atherosclerosis 2017;260:41=6.
Blomberg BA, Thomassen A, de Jong PA, et al. Coronary fluorine-18-sodium fluoride uptake is increased in healthy adults with an unfavorable cardiovascular risk profile: Results from the CAMONA study. Nucl Med Commun 2017;38:1007=14.
Blomberg BA, de Jong PA, Thomassen A, et al. Thoracic aorta calcification but not inflammation is associated with increased cardiovascular disease risk: Results of the CAMONA study. Eur J Nucl Med Mol Imaging 2017;44:249=58.
Dweck MR, Chow MW, Joshi NV, et al. Coronary arterial 18F-sodium fluoride uptake: A novel marker of plaque biology. J Am Coll Cardiol 2012;59:1539-48.
Kitagawa T, Yamamoto H, Toshimitsu S, et al. (18)F-sodium fluoride positron emission tomography for molecular imaging of coronary atherosclerosis based on computed tomography analysis. Atherosclerosis 2017;263:385-92.
Lee JM, Bang JI, Koo BK, et al. Clinical relevance of 18F-sodium fluoride positron-emission tomography in noninvasive identification of high-risk plaque in patients with coronary artery disease. Circ Cardiovasc Imaging 2017. https://doi.org/10.1161/CIRCIMAGING.117.006704.
Marchesseau S, Seneviratna A, Sjoholm AT, et al. Hybrid PET/CT and PET/MRI imaging of vulnerable coronary plaque and myocardial scar tissue in acute myocardial infarction. J Nucl Cardiol 2017. https://doi.org/10.1007/s12350-017-0918-8.
Quirce R, Martinez-Rodriguez I, De Arcocha Torres M, et al. Contribution of 18F-sodium fluoride PET/CT to the study of the carotid atheroma calcification. Rev Esp Med Nucl Imagen Mol 2013;32:22-5.
Quirce R, Martinez-Rodriguez I, Banzo I, et al. New insight of functional molecular imaging into the atheroma biology: 18F-NaF and 18F-FDG in symptomatic and asymptomatic carotid plaques after recent CVA. Preliminary results. Clin Physiol Funct Imaging 2016;36:499-503.
Zhang Y, Li H, Jia Y, et al. Noninvasive assessment of carotid plaques calcification by (18)F-sodium fluoride accumulation: Correlation with pathology. J Stroke Cerebrovasc Dis 2018;27:1796-801.
Hyafil F, Messika-Zeitoun D, Burg S, et al. Detection of 18fluoride sodium accumulation by positron emission tomography in calcified stenotic aortic valves. Am J Cardiol 2012;109:1194-6.
Dweck MR, Jones C, Joshi NV, et al. Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis. Circulation 2012;125:76-86.
Dweck MR, Khaw HJ, Sng GK, et al. Aortic stenosis, atherosclerosis, and skeletal bone: Is there a common link with calcification and inflammation? Eur Heart J 2013;34:1567-74.
Dweck MR, Jenkins WS, Vesey AT, et al. 18F-sodium fluoride uptake is a marker of active calcification and disease progression in patients with aortic stenosis. Circ Cardiovasc Imaging 2014;7:371-8.
Forsythe RO, Dweck MR, McBride OMB, et al. (18)F-sodium fluoride uptake in abdominal aortic aneurysms: The SoFIA(3) study. J Am Coll Cardiol 2018;71:513-23.
Alexanderson-Rosas E, Monroy-Gonzalez AG, Juarez-Orozco LE, et al. [(18)F]-sodium fluoride uptake in Takayasu arteritis. J Nucl Cardiol 2017;24:1674-9.
Beheshti M, Saboury B, Mehta NN, et al. Detection and global quantification of cardiovascular molecular calcification by fluoro18-fluoride positron emission tomography/computed tomography—A novel concept. Hell J Nucl Med 2011;14:114-20.
Morbelli S, Fiz F, Piccardo A, et al. Divergent determinants of 18F-NaF uptake and visible calcium deposition in large arteries: Relationship with Framingham risk score. Int J Cardiovasc Imaging 2014;30:439-47.
Fiz F, Morbelli S, Piccardo A, et al. (1)(8)F-NaF uptake by atherosclerotic plaque on PET/CT imaging: Inverse correlation between calcification density and mineral metabolic activity. J Nucl Med 2015;56:1019-23.
Li X, Heber D, Cal-Gonzalez J, et al. Association between osteogenesis and inflammation during the progression of calcified plaque evaluated by (18)F-fluoride and (18)F-FDG. J Nucl Med 2017;58:968-74.
McKenney-Drake ML, Moghbel MC, Paydary K, et al. (18)F-NaF and (18)F-FDG as molecular probes in the evaluation of atherosclerosis. Eur J Nucl Med Mol Imaging 2018;45:2190-200.
Stone GW, Maehara A, Lansky AJ, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med 2011;364:226-35.
Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: A call for new definitions and risk assessment strategies: Part I. Circulation 2003;108:1664-72.
Williams MC, Moss AJ, Dweck M, et al. Coronary artery plaque characteristics associated with adverse outcomes in the SCOT-HEART study. J Am Coll Cardiol 2019;73:291-301.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
The authors declare no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Funding
The authors received no specific funding for this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Silva Mendes, B.I., Oliveira-Santos, M. & Vidigal Ferreira, M.J. Sodium fluoride in cardiovascular disorders: A systematic review. J. Nucl. Cardiol. 28, 1461–1473 (2021). https://doi.org/10.1007/s12350-019-01832-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12350-019-01832-7